secondary progressive multiple sclerosis
Showing 1 - 25 of 43
Mayzent Onboarding of Secondary Progressive Multiple Sclerosis
Completed
- Secondary Progressive Multiple Sclerosis
-
Camperdown, New South Wales, Australia
- +1 more
Apr 19, 2023
Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United
Recruiting
- Relapsing Multiple Sclerosis
- +2 more
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
-
Palo Alto, California
- +20 more
Jan 25, 2023
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic
Not yet recruiting
- Relapsing Remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- Glycemic load
- +2 more
-
Birmingham, Alabama
- +1 more
Jan 4, 2023
Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))
Active, not recruiting
- Secondary Progressive Multiple Sclerosis
- BAF312
- Baseline disease modifying therapies (DMTs)
-
Mittweida, Sachsen, Germany
- +9 more
Aug 9, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States
Active, not recruiting
- Primary Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- ATA188
- Placebo
-
La Jolla, California
- +33 more
Jul 21, 2022
Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City
Recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- Ferumoxytol infusion
- +2 more
-
Salt Lake City, UtahUniversity of Utah Health Imaging and Neurosciences Center
Jun 22, 2022
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral
Recruiting
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Metformin 500 Mg Oral Tablet, up to 4 tablets a day
- Placebo oral tablet identical to metformin, up to 4 tablets a day
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 2, 2022
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial
Recruiting
- Relapsing Remitting Multiple Sclerosis
- +2 more
- Rituximab
- +4 more
-
Glostrup, Copenhagen, Denmark
- +11 more
May 3, 2022
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial
Active, not recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- ACTH
- Placebo
-
Minneapolis, Minnesota
- +2 more
Mar 29, 2022
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Caen (Cognitive rehabilitation,
Recruiting
- Relapsing Remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- Cognitive rehabilitation
- Standard Psychological care
-
Caen, Calvados, FranceUniversity Hospital of Caen
Mar 8, 2022
Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial
Recruiting
- Relapsing Remitting Multiple Sclerosis
- +2 more
- Ixazomib (NINLARO®) capsules / Matching placebo capsules
-
London, Greater London, United KingdomRoyal London Hospital, Barts Health NHS Foundation Trust
Feb 17, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab
Withdrawn
- Primary Progressive Multiple Sclerosis
- +2 more
- Intranasal Foralumab Solution
- Placebo
- (no location specified)
Feb 14, 2022
Measuring Active Microglia in Progressive Multiple Sclerosis
Completed
- Secondary Progressive Multiple Sclerosis
- [C11]PK-1195 PET scan
-
New York, New YorkWeill Cornell Medical College
Jan 14, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston
Recruiting
- Primary Progressive Multiple Sclerosis
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2021
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)
Completed
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Fampridine
- Placebo
-
Dublin, Dublin 4, Ireland
- +1 more
Jul 8, 2021
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
Completed
- Relapsing-remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
-
London, United KingdomImperial College NHS Trust
Feb 11, 2021
Phase III Trial With BAF312 in Secondary Progressive Multiple
Completed
- Secondary Progressive Multiple Sclerosis
- Blood Draw
- CSF collection by lumbar puncture (Optional)
-
Berkeley, California
- +12 more
Nov 5, 2020
Secondary Progressive Multiple Sclerosis Trial in Nottingham (Acceptance Based Telephone Support (ABS+UC))
Completed
- Secondary Progressive Multiple Sclerosis
- Acceptance Based Telephone Support (ABS+UC)
-
Nottingham, Nottinghamshire, United KingdomQueens Medical Centre, Nottingham
Sep 24, 2020
Secondary Progressive Multiple Sclerosis Trial in London (Simvastatin)
Unknown status
- Secondary Progressive Multiple Sclerosis
-
London, United KingdomDepartment of Neuroinflammation, UCL Institute of Neurology
Mar 27, 2020
Secondary Progressive Multiple Sclerosis Trial in United Kingdom (Amiloride, Riluzole, Fluoxetine)
Completed
- Secondary Progressive Multiple Sclerosis
- Amiloride
- +3 more
-
Edinburgh, United Kingdom
- +12 more
Mar 25, 2020
Secondary Progressive Multiple Sclerosis Trial in Baltimore (Active cycling, Passive cycling)
Completed
- Secondary Progressive Multiple Sclerosis
- Active cycling
- Passive cycling
-
Baltimore, MarylandJohns Hopkins / Kennedy Krieger Institute
Mar 18, 2020
Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Barcelona (XCEL-MC-ALPHA, Placebo)
Completed
- Relapsing-Remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- XCEL-MC-ALPHA
- Placebo
-
Barcelona, SpainHospital Vall Hebron
Jan 15, 2020
Secondary Progressive Multiple Sclerosis Trial in Chalfont St. Peter, Hammersmith, Brighton (Simvastatin, Placebo)
Completed
- Secondary Progressive Multiple Sclerosis
- Simvastatin
- Placebo
-
Chalfont St. Peter, Buckinghamshire, United Kingdom
- +2 more
Nov 21, 2019
Secondary Progressive Multiple Sclerosis Trial in Ann Arbor (SoluMedrol, Extracorporeal Photopheresis)
Terminated
- Secondary Progressive Multiple Sclerosis
- SoluMedrol
- Extracorporeal Photopheresis
-
Ann Arbor, MichiganUniversity of Michigan Health Systems
Aug 8, 2019
Secondary Progressive Multiple Sclerosis Trial in Isfahan (Rituximab, Glatiramer Acetate)
Completed
- Secondary Progressive Multiple Sclerosis
- Rituximab
- Glatiramer Acetate
-
Isfahan, Iran, Islamic Republic ofKashani Hospital
May 22, 2019